Rakovina Therapeutics Inc.
Streetwise Company Fact Sheet2026/10/6 17:05:01
(RKV:TSX.V - RKVTF:OTCPK - 7JO0:FSE)
Analyst coverage
| Leede Financial Inc. — Dr. Douglas Loe |
Company News
| View Latest News |
Streetwise Reports Articles
| 10/06/2026 - View Article |
| 09/03/2026 - View Article |
| 09/03/2026 - View Article |
| 08/13/2026 - View Article |
| 06/05/2026 - View Article |
Streetwise - Rakovina Therapeutics Inc. Ownership Overview*
Rakovina Therapeutics Inc. (RKV:TSX.V;RKVTF:OTCPK;7JO0:FSE)
| Date | Old Symbol | Old Shares | New Symbol | New Shares |
|---|---|---|---|---|
| 06/24/25 | RKV:TSX.V | 10 | RKV:TSX.V | 1 |
| 04/01/21 | VCO.P:TSX.V | 1 | RKV:TSX.V | 1 |
Company News
10/1/2026 – Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development
8/31/2026 – Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
8/31/2026 – Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
8/19/2026 – Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
8/12/2026 – Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
7/15/2026 – Rakovina Therapeutics Announces $1.5 Million Private Placement
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
